慢性移植对宿主疾病,第2部分:临床成功和未来的路线图
Najla El Jurdi1, Bruce R Blazar2, Steven Z Pavletic1
1Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Transplantation
|February 7, 2025
概括
慢性移植与宿主疾病 (cGVHD) 管理需要早期检测和个性化护理. 虽然新的治疗方法改善了结果,但中度至重度cGVHD仍然具有挑战性,需要对预防性和新型治疗策略的持续研究.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 慢性移植与宿主疾病 (cGVHD) 是异构造血细胞移植后的一个主要并发症.
- 它导致显著的发病率,死亡率和移植接受者的生活质量下降.
- 尽管取得了进展,但对中度至重度cGVHD的结果仍然不够理想.
研究的目的:
- 审查目前的研究和cGVHD治疗方法的新发展.
- 突出预防性治疗,预先治疗和耐火性cGVHD的新药的进展.
- 讨论组合疗法,器官特定策略和未来的研究方向.
主要方法:
- 关于cGVHD近期临床研究和治疗进展的文献综述.
- 专注于国家卫生研究院指导的标准化和床边工作.
- 对FDA批准的药物和新兴治疗方法的分析.
主要成果:
- 自2017年以来,已经出现了四种FDA批准的类固醇耐火性cGVHD药物.
- 早期识别疾病对于有效的多学科干预至关重要.
- 活跃的研究领域包括预防性,前期和新型组合疗法.
结论:
- 尽管取得了进展,但管理中度至重度cGVHD需要进一步的创新.
- 个人化,多学科的护理,整合药理和支持措施是必不可少的.
- 解决当前知识中的挑战和差距将指导未来的cGVHD治疗策略.
更多相关视频
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
相关概念视频
01:40Cell-mediated Immune Responses
66.7K
Overview
66.7K
01:22Bone Marrow Sampling and Transplants
277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277
01:24Tissue Transplantation
332
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
332